Literature DB >> 25825716

Alternative splicing of the androgen receptor in polycystic ovary syndrome.

Fangfang Wang1, Jiexue Pan1, Ye Liu1, Qing Meng1, Pingping Lv1, Fan Qu1, Guo-Lian Ding2, Christian Klausen3, Peter C K Leung3, Hsiao Chang Chan4, Weimiao Yao5, Cai-Yun Zhou5, Biwei Shi5, Junyu Zhang2, Jianzhong Sheng6, Hefeng Huang7.   

Abstract

Polycystic ovary syndrome (PCOS) is one of the most common female endocrine disorders and a leading cause of female subfertility. The mechanism underlying the pathophysiology of PCOS remains to be illustrated. Here, we identify two alternative splice variants (ASVs) of the androgen receptor (AR), insertion and deletion isoforms, in granulosa cells (GCs) in ∼62% of patients with PCOS. AR ASVs are strongly associated with remarkable hyperandrogenism and abnormalities in folliculogenesis, and are absent from all control subjects without PCOS. Alternative splicing dramatically alters genome-wide AR recruitment and androgen-induced expression of genes related to androgen metabolism and folliculogenesis in human GCs. These findings establish alternative splicing of AR in GCs as the major pathogenic mechanism for hyperandrogenism and abnormal folliculogenesis in PCOS.

Entities:  

Keywords:  AR; PCOS; folliculogenesis; hyperandrogenism; splicing

Mesh:

Substances:

Year:  2015        PMID: 25825716      PMCID: PMC4403157          DOI: 10.1073/pnas.1418216112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Combining evidence using p-values: application to sequence homology searches.

Authors:  T L Bailey; M Gribskov
Journal:  Bioinformatics       Date:  1998       Impact factor: 6.937

2.  Molecular analysis of the androgen-receptor gene in a family with receptor-positive partial androgen insensitivity: an unusual type of intronic mutation.

Authors:  H T Brüggenwirth; A L Boehmer; S Ramnarain; M C Verleun-Mooijman; D P Satijn; J Trapman; J A Grootegoed; A O Brinkmann
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

Review 3.  Role of androgens in follicle maturation and atresia.

Authors:  S G Hillier; M Tetsuka
Journal:  Baillieres Clin Obstet Gynaecol       Date:  1997-06

Review 4.  Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones.

Authors:  Anita H Payne; Dale B Hales
Journal:  Endocr Rev       Date:  2004-12       Impact factor: 19.871

5.  Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries.

Authors:  Sharron A Stubbs; Kate Hardy; Patricia Da Silva-Buttkus; Jaroslav Stark; Lisa J Webber; Adrienne M Flanagan; Axel P N Themmen; Jenny A Visser; Nigel P Groome; Stephen Franks
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

6.  Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription.

Authors:  A M Moilanen; H Poukka; U Karvonen; M Häkli; O A Jänne; J J Palvimo
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

7.  Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells.

Authors:  Jonas Bondestam; Noora Kaivo-oja; Janne Kallio; Nigel Groome; Christel Hydén-Granskog; Makiko Fujii; Aristidis Moustakas; Anu Jalanko; Peter ten Dijke; Olli Ritvos
Journal:  Mol Cell Endocrinol       Date:  2002-09-30       Impact factor: 4.102

8.  TRANSFAC: transcriptional regulation, from patterns to profiles.

Authors:  V Matys; E Fricke; R Geffers; E Gössling; M Haubrock; R Hehl; K Hornischer; D Karas; A E Kel; O V Kel-Margoulis; D-U Kloos; S Land; B Lewicki-Potapov; H Michael; R Münch; I Reuter; S Rotert; H Saxel; M Scheer; S Thiele; E Wingender
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

9.  Formation and early development of follicles in the polycystic ovary.

Authors:  L J Webber; S Stubbs; J Stark; G H Trew; R Margara; K Hardy; S Franks
Journal:  Lancet       Date:  2003-09-27       Impact factor: 79.321

Review 10.  Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects.

Authors:  R Ferraldeschi; J Welti; J Luo; G Attard; J S de Bono
Journal:  Oncogene       Date:  2014-05-19       Impact factor: 9.867

View more
  28 in total

Review 1.  Ovarian and Extra-Ovarian Mediators in the Development of Polycystic Ovary Syndrome.

Authors:  Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  J Mol Endocrinol       Date:  2018-10-16       Impact factor: 5.098

2.  Current concepts of polycystic ovary syndrome pathogenesis.

Authors:  Robert L Rosenfield
Journal:  Curr Opin Pediatr       Date:  2020-10       Impact factor: 2.856

3.  Western-style diet, with and without chronic androgen treatment, alters the number, structure, and function of small antral follicles in ovaries of young adult monkeys.

Authors:  Cecily V Bishop; Fuhua Xu; Jing Xu; Alison Y Ting; Etienne Galbreath; Whitney K McGee; Mary B Zelinski; Jon D Hennebold; Judy L Cameron; Richard L Stouffer
Journal:  Fertil Steril       Date:  2015-12-21       Impact factor: 7.329

4.  Tracing and Characterizing the Development of Transplanted Female Germline Stem Cells In Vivo.

Authors:  Changqing Wu; Bo Xu; Xiaoyong Li; Wenzhi Ma; Ping Zhang; Xuejin Chen; Ji Wu
Journal:  Mol Ther       Date:  2017-05-18       Impact factor: 11.454

5.  American, European, and Chinese practice guidelines or consensuses of polycystic ovary syndrome: a comparative analysis.

Authors:  Fang-Fang Wang; Jie-Xue Pan; Yan Wu; Yu-Hang Zhu; Paul J Hardiman; Fan Qu
Journal:  J Zhejiang Univ Sci B       Date:  2018-05       Impact factor: 3.066

6.  Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome.

Authors:  Aimee S L Caldwell; Melissa C Edwards; Reena Desai; Mark Jimenez; Robert B Gilchrist; David J Handelsman; Kirsty A Walters
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

7.  VCAM1 Is Induced in Ovarian Theca and Stromal Cells in a Mouse Model of Androgen Excess.

Authors:  Nicholes R Candelaria; Achuth Padmanabhan; Fabio Stossi; M Cecilia Ljungberg; Katharine E Shelly; Braden K Pew; Minerva Solis; Ayane M Rossano; Jan M McAllister; Sheng Wu; JoAnne S Richards
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

Review 8.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

9.  Novel PGK1 determines SKP2-dependent AR stability and reprograms granular cell glucose metabolism facilitating ovulation dysfunction.

Authors:  Xia Liu; Changfa Sun; Kexin Zou; Cheng Li; Xiaojun Chen; Hangchao Gu; Zhiyang Zhou; Zuwei Yang; Yaoyao Tu; Ningxin Qin; Yiran Zhao; Yimei Wu; Yicong Meng; Guolian Ding; Xinmei Liu; Jianzhong Sheng; Chuanjin Yu; Hefeng Huang
Journal:  EBioMedicine       Date:  2020-10-21       Impact factor: 8.143

10.  Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome.

Authors:  Sanjiv Risal; Yu Pei; Haojiang Lu; Maria Manti; Romina Fornes; Han-Pin Pui; Zhiyi Zhao; Julie Massart; Claes Ohlsson; Eva Lindgren; Nicolas Crisosto; Manuel Maliqueo; Barbara Echiburú; Amanda Ladrón de Guevara; Teresa Sir-Petermann; Henrik Larsson; Mina A Rosenqvist; Carolyn E Cesta; Anna Benrick; Qiaolin Deng; Elisabet Stener-Victorin
Journal:  Nat Med       Date:  2019-12-02       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.